The authors previously reported that eradication of Helicobacter pylori in the cohort of patients with peptic ulcer disease reduced their risk of developing gastric cancer to approximately one–third after a mean follow-up period of 3.4 years (up to 8.6 years) and now followed these patients for a longer period.

A prophylactic effect for gastric cancer persists for more than 10 years after H. pylori eradication therapy, but they should be aware that cancer can develop even after that interval.

READ FULL ARTICLE Curated publisher From Mdlinx